Dupilumab improved outcomes among patients with severe chronic rhinosinusitis with nasal polyps across a range of type 2 inflammatory signatures, according to data presented at EAACI Hybrid Congress 2023 in Hamburg, Germany. Treatment also reduced local and systemic type 2 inflammation biomarkers and was well tolerated, Claus Bachert, MD, PhD, department of otorhinolaryngology, head and neck
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis – Authors reply thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.